An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

被引:101
作者
Davi, Sergio [1 ]
Consolaro, Alessandro [1 ]
Guseinova, Dinara [1 ]
Pistorio, Angela [1 ]
Ruperto, Nicolino [1 ]
Martini, Alberto [1 ,2 ]
Cron, Randy Q. [3 ,4 ]
Ravelli, Angelo [1 ,2 ]
机构
[1] Ist Ricovero & Cura Carattere Sci G Gaslini, Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] Childrens Hosp Alabama, Birmingham, AL USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
关键词
MACROPHAGE ACTIVATION SYNDROME; HEMOPHAGOCYTIC SYNDROME; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DIAGNOSTIC CRITERIA; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; DERMATOMYOSITIS; GUIDELINES;
D O I
10.3899/jrheum.100996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To identify candidate diagnostic criteria for macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA) using international consensus formation through a Delphi questionnaire survey. Methods. A questionnaire listing 28 clinical, laboratory, and histopathologic features of MAS elicited by literature review was sent to 505 pediatric rheumatologists worldwide. Respondents were asked to select the 10 features that they felt were most important and useful in the diagnosis of MAS, and to order the 10 selected features by assigning the number 10 to the most important, and ending with 1 as the least important. Results. The response rate was 46% (232 physicians from 47 countries). The items selected by more than 50% of respondents were, in order of frequency, falling platelet count, hyperferritinemia, evidence of macrophage hemophagocytosis in the bone marrow, increased liver enzymes, falling leukocyte count, persistent continuous fever >= 38 degrees C, falling erythrocyte sedimentation rate, hypofibrinogenemia, and hypertriglyceridemia. Conclusion. Our process led to identification of features that were felt to be most important as candidate diagnostic criteria for MAS by a large sample of international pediatric rheumatologists. (First Release Feb 1 2011; J Rheumatol 2011;38:764-8: doi:10.3899/jrheum.100996)
引用
收藏
页码:764 / 768
页数:5
相关论文
共 20 条
[1]  
Behrens EM, 2007, J RHEUMATOL, V34, P1133
[2]   The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis [J].
Bleesing, Jack ;
Prada, Anne ;
Siegel, David M. ;
Villanueva, Joyce ;
Olson, Judyann ;
Ilowite, Norman T. ;
Brunner, Hermine I. ;
Griffin, Thomas ;
Graham, Thomas B. ;
Sherry, David D. ;
Passo, Murray H. ;
Ramanan, Athimalaipet V. ;
Filipovich, Alexandra ;
Grom, Alexei A. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (03) :965-971
[3]   An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM) [J].
Brown, V. E. ;
Pilkington, C. A. ;
Feldman, B. M. ;
Davidson, J. E. .
RHEUMATOLOGY, 2006, 45 (08) :990-993
[4]   Toward the Development of Criteria for Global Flares in Juvenile Systemic Lupus Erythematosus [J].
Brunner, Hermine I. ;
Klein-Gitelman, Marisa S. ;
Higgins, Gloria C. ;
Lapidus, Sivia K. ;
Levy, Deborah M. ;
Eberhard, Anne ;
Singer, Nora ;
Olson, Judyann C. ;
Onel, Karen ;
Punaro, Marilynn ;
Schanberg, Laura ;
von Scheven, Emily ;
Ying, Jun ;
Giannini, Edward H. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :811-820
[5]  
Delbecq A.L., 1975, GROUP TECHNIQUES PRO
[6]  
Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202
[7]  
Grom AA, 1996, J PEDIATR-US, V129, P630
[8]   Macrophage activation syndrome: advances towards understanding pathogenesis [J].
Grom, Alexei A. ;
Mellins, Elizabeth D. .
CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (05) :561-566
[9]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[10]  
PALMISANI E, 2010, P 17 PED RHEUM EUR S, P260